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Background
Statistical significance between serum 25(OH)D levels and
headache in the pediatric population is still controversial.
However, a supplementary vitamin D therapy in children
with headache allowed us to note an improvement in the
clinical symptoms in terms of frequency and severity [1].
Aim
To study vitamin D blood levels in primary headaches
and to show the relationship with clinical parameters
influencing clinical course of the headache.
Materials and methods
Sixty-seven males (42%) and 92 females (58%), aged
between 5 to 18 years, suffering from headache, were
divided into three diagnostic categories, according to the
ICHD-III classification: migraine with aura (MWA),
migraine without aura (MWoA) and tension-type head-
ache (TTH). Serum vitamin D level lower than 20 ng/ml
was considered pathological. Immunohistochemical meth-
ods of chemiluminescence were used to determine blood
25(OH)D level.
Results
Ninety-one patients (57%) received a diagnosis of MWoA,
32 (20%) of MWA and 36 (23%) of TTH. Hypovitaminosis
D was found in 56% of the children with MWoA, in 50%
of patients with MWA and in 44.4% with TTH. Twelve
percent of all the sample showed severe Hypovitaminosis
D (<10 ng/ml). There were neither statistically significant
differences comparing vitamin D serum levels between
males and females in each category of headache (p = 0.36),
nor more severe deficiency of vitamin D in overweight
children with BMI>90°C (p = 0.47), and serum concentra-
tion was not lower in adolescents and pre-adolescent than
children under 10 years. A difference resulted in the limits
of statistical significance (p = 0.07) in 25(OH)D serum
level in children with MWoA compared to patients with
MWA and THH.
Conclusions
Our study shows a high incidence of vitamin D deficiency
in the pediatric population with headache (56%), particu-
larly in migraineurs without aura [2]. Probably this defi-
ciency could be directly correlated with a higher frequency
of migraine attacks in children with MWoA.
Written informed consent to publication was obtained
from the patient(s).
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